Jan Berger
CEO
Health Intelligence Partners
-
Jan is an independent director with significant board and committee experience, a Chief Executive Officer, a Fortune 20 corporate officer, an author, and a keynote speaker. Jan has proven success in public, private and government service over the last 30 years in both healthcare and consumer goods/services. This tri-sector experience has been translated into her roles in the boardroom. For 11 years, Jan served as Executive Vice President, Chief Innovation and Medical Officer for CVS Health responsible for a $500 million dollar division of the company. During that time, she was a corporate officer and on the executive team with a broad set of responsibilities including Minute Clinic, government programs, clinical programs and ancillary services. In addition to her corporate work, Jan has diverse and deep experience on publicly traded, privately held and P.E based corporate boards both in the U.S. and Internationally. Jan’s board leadership experience includes healthcare, life sciences, veterinary and consumer product boards. Her board experience has given Jan experience in crisis management, activist, and M & A activities.
She presently sits on healthcare and life sciences-focused boards including UCB Pharmaceuticals, BC Platform, Upfront Healthcare and Aitia Healthcare (Lead Independent Board Member, Vice Chair of the Board, Chair of Compensation and Governance, Member: Audit Committee; Jan’s previous board experience includes: Cambia Health Solutions (Audit & Compliance Committee, Health Services Committee), Tabula Rasa (Public.. Member: Nominations, Audit, Governance, Strategy), Voluntis (Public. Chair, M&A/Strategy Committee, Nomination and Compensation Committee), Care Core National (Member: Audit and Finance Committee, Compensation, M&A and Strategy), AccentCare (Chair; Compliance Committee, Member: Compensation Committee), Chip Rewards, Qliance, C3, University of Arizona School of Pharmacy, Blue Cross and Blue Shield Western Conference Board of Directors and Rx-Ante. Jan has recently released, Re-Engaging in Trust: The Missing Ingredient in Fixing Healthcare. As the author of five books and editorial activity on several healthcare journals, Jan is considered a national thought leader on the importance of creating trust as a foundation in an organization’s corporate sustainability strategies.
Key boards: Aitia Healthcare, BC Platform, UCB Pharmaceuticals, Upfront Healthcare
CEO
Health Intelligence Partners
-
Jan is an independent director with significant board and committee experience, a Chief Executive Officer, a Fortune 20 corporate officer, an author, and a keynote speaker. Jan has proven success in public, private and government service over the last 30 years in both healthcare and consumer goods/services. This tri-sector experience has been translated into her roles in the boardroom. For 11 years, Jan served as Executive Vice President, Chief Innovation and Medical Officer for CVS Health responsible for a $500 million dollar division of the company. During that time, she was a corporate officer and on the executive team with a broad set of responsibilities including Minute Clinic, government programs, clinical programs and ancillary services. In addition to her corporate work, Jan has diverse and deep experience on publicly traded, privately held and P.E based corporate boards both in the U.S. and Internationally. Jan’s board leadership experience includes healthcare, life sciences, veterinary and consumer product boards. Her board experience has given Jan experience in crisis management, activist, and M & A activities.
She presently sits on healthcare and life sciences-focused boards including UCB Pharmaceuticals, BC Platform, Upfront Healthcare and Aitia Healthcare (Lead Independent Board Member, Vice Chair of the Board, Chair of Compensation and Governance, Member: Audit Committee; Jan’s previous board experience includes: Cambia Health Solutions (Audit & Compliance Committee, Health Services Committee), Tabula Rasa (Public.. Member: Nominations, Audit, Governance, Strategy), Voluntis (Public. Chair, M&A/Strategy Committee, Nomination and Compensation Committee), Care Core National (Member: Audit and Finance Committee, Compensation, M&A and Strategy), AccentCare (Chair; Compliance Committee, Member: Compensation Committee), Chip Rewards, Qliance, C3, University of Arizona School of Pharmacy, Blue Cross and Blue Shield Western Conference Board of Directors and Rx-Ante. Jan has recently released, Re-Engaging in Trust: The Missing Ingredient in Fixing Healthcare. As the author of five books and editorial activity on several healthcare journals, Jan is considered a national thought leader on the importance of creating trust as a foundation in an organization’s corporate sustainability strategies.
Key boards: Aitia Healthcare, BC Platform, UCB Pharmaceuticals, Upfront Healthcare
Michele Colucci JD, MFA
Managing Partner
DigitalDx Ventures
-
Michele Colucci is a venture capital thought leader, lawyer, investor, serial entrepreneur, and philanthropist. She holds multiple patents in the technology space and founded companies in the legal, technology, retail, and entertainment spaces. Her extensive experience operating in highly regulated verticals includes management, nom/gov, audit/financial, strategic, marketing, and legal. As a venture capitalist focused on AI and med tech, Colucci is committed to impacting the health field by investing in companies using technology to enable doctors and patients to make better, earlier, and less invasive diagnostic decisions.
She has board of director experience with public and private firms, past and present, including Global Indemnity Group, Biotia, Nephrosant, Optina Diagnostics, Prime Genomics, NowDx, Delphi Diagnostics, Trayt, and GLX Analytix. She has been a frequent guest lecturer at Stanford University’s School of Engineering. In 2017, Colucci was named West Coast Ambassador by the Nobel Laureate Foundation, and in 2023 she was awarded Best MedTech Investor by Silicon Valley’s Gentry Magazine. Her venture fund, DigitalDx Ventures, has been recognized in 2023 as Most Innovative ESG Initiative and Best Diversity Initiative by PEI Media. She earned her B.A. and J.D. from Georgetown University and an M.F.A from the AFI.
Key boards: Optina Diagnostics, Prime Genomics (Chair), Biotia
Managing Partner
DigitalDx Ventures
-
Michele Colucci is a venture capital thought leader, lawyer, investor, serial entrepreneur, and philanthropist. She holds multiple patents in the technology space and founded companies in the legal, technology, retail, and entertainment spaces. Her extensive experience operating in highly regulated verticals includes management, nom/gov, audit/financial, strategic, marketing, and legal. As a venture capitalist focused on AI and med tech, Colucci is committed to impacting the health field by investing in companies using technology to enable doctors and patients to make better, earlier, and less invasive diagnostic decisions.
She has board of director experience with public and private firms, past and present, including Global Indemnity Group, Biotia, Nephrosant, Optina Diagnostics, Prime Genomics, NowDx, Delphi Diagnostics, Trayt, and GLX Analytix. She has been a frequent guest lecturer at Stanford University’s School of Engineering. In 2017, Colucci was named West Coast Ambassador by the Nobel Laureate Foundation, and in 2023 she was awarded Best MedTech Investor by Silicon Valley’s Gentry Magazine. Her venture fund, DigitalDx Ventures, has been recognized in 2023 as Most Innovative ESG Initiative and Best Diversity Initiative by PEI Media. She earned her B.A. and J.D. from Georgetown University and an M.F.A from the AFI.
Key boards: Optina Diagnostics, Prime Genomics (Chair), Biotia
Sharon Gabrielson
Founder and CEO
SRG Associates
Sharon Gabrielson is a global, C-level healthcare executive and independent board member with a successful track record of driving growth and building organizations at scale in both the public and private sectors. She is the Founder and CEO of SRG Associates, a C-suite and board advisory company. Sharon's experience includes leadership roles at The Mayo Clinic, Olmsted Medical Center, and LifeSource.
As a board director of public and private companies, Sharon provides valuable insights on strategic growth, M&A, digital transformation, healthcare ecosystems, ESG, risk management, and organizational change management. Through a broad strategic lens shaped by independent director roles in public, PE-backed, for-profit, and non-profit organizations, Sharon advises on growth strategies and corporate development transactions that accelerate value creation.
Sharon’s current boards include MTF Biologics and PracticeWise, where she serves as chair of the board. Past board roles include chair of the board of Sharps Compliance (NASDAQ: SMED), Catasys (NASDAQ: CATS), and Ethos Veterinary Health.
Founder and CEO
SRG Associates
Sharon Gabrielson is a global, C-level healthcare executive and independent board member with a successful track record of driving growth and building organizations at scale in both the public and private sectors. She is the Founder and CEO of SRG Associates, a C-suite and board advisory company. Sharon's experience includes leadership roles at The Mayo Clinic, Olmsted Medical Center, and LifeSource.
As a board director of public and private companies, Sharon provides valuable insights on strategic growth, M&A, digital transformation, healthcare ecosystems, ESG, risk management, and organizational change management. Through a broad strategic lens shaped by independent director roles in public, PE-backed, for-profit, and non-profit organizations, Sharon advises on growth strategies and corporate development transactions that accelerate value creation.
Sharon’s current boards include MTF Biologics and PracticeWise, where she serves as chair of the board. Past board roles include chair of the board of Sharps Compliance (NASDAQ: SMED), Catasys (NASDAQ: CATS), and Ethos Veterinary Health.
Deborah Gage
CEO, Advisor
FitOn, Laguna, TPN, HearMe, Avesi & GrowthCurve
-
Deborah is a CEO and board member with 20+ years of C-suite experience at companies ranging from startups to Fortune 100. Deb built her career as an entrepreneur, founding, transforming, and leading healthcare technology companies that provide SaaS enterprise platforms for analytics, financial, and clinical applications in the healthcare industry.
Deborah is an active board member for both private and non-profit organizations. She is currently the Chair of the Board of HearMe Corporation and serves as a board member of FitOn Health. She also currently sits on the advisory boards of Recurro Health and Laguna. Deb is also a member of the board at The Grand Canyon Conservancy. She has previously served on the boards of directors of Medecision, GTESS Corporation, RosettaMed, and Solution Point, and on the advisory boards of Aveus and SourceMed.
Deb has an active advisory business where she serves in interim operating roles for businesses in the care management, telehealth, and behavioral health segments. She is also a limited partner at Hc9 and an advisor to PE and venture firms.
In her most recent CEO role, Deborah was President and Chief Executive of Medecision from 2011 to 2021, where she led the turn-around and profitable growth of the company to over $100M, establishing the company’s mission and market leading position as a digital transformation partner in care management and consumer engagement.
Deborah earned a BA in Economics from the University of Michigan and an MBA from the Ross School of Business at the University of Michigan.
Key boards: HearMe Corporation (Chair), FitOn
CEO, Advisor
FitOn, Laguna, TPN, HearMe, Avesi & GrowthCurve
-
Deborah is a CEO and board member with 20+ years of C-suite experience at companies ranging from startups to Fortune 100. Deb built her career as an entrepreneur, founding, transforming, and leading healthcare technology companies that provide SaaS enterprise platforms for analytics, financial, and clinical applications in the healthcare industry.
Deborah is an active board member for both private and non-profit organizations. She is currently the Chair of the Board of HearMe Corporation and serves as a board member of FitOn Health. She also currently sits on the advisory boards of Recurro Health and Laguna. Deb is also a member of the board at The Grand Canyon Conservancy. She has previously served on the boards of directors of Medecision, GTESS Corporation, RosettaMed, and Solution Point, and on the advisory boards of Aveus and SourceMed.
Deb has an active advisory business where she serves in interim operating roles for businesses in the care management, telehealth, and behavioral health segments. She is also a limited partner at Hc9 and an advisor to PE and venture firms.
In her most recent CEO role, Deborah was President and Chief Executive of Medecision from 2011 to 2021, where she led the turn-around and profitable growth of the company to over $100M, establishing the company’s mission and market leading position as a digital transformation partner in care management and consumer engagement.
Deborah earned a BA in Economics from the University of Michigan and an MBA from the Ross School of Business at the University of Michigan.
Key boards: HearMe Corporation (Chair), FitOn
Daphne Jones MBA
Founder & Concierge
The Board Curators
-
Daphne E. Jones is a highly accomplished Fortune 500 CIO, digital leader, and board member with over 30 years of experience in general management and executive-level roles at leading companies such as IBM, Johnson & Johnson, Hospira, and General Electric. With a reputation for innovation and driving business growth, Jones has held several leadership positions at GE, including SVP for Future of Work, SVP and CIO for Product Engineering, Imaging, and Ultrasound, and Senior Executive and CIO for Global Services, where she led a $13 billion segment of GE Healthcare.
Jones is also an acclaimed author, having recently published her first book, "WIN WHEN THEY SAY YOU WON’T: Break Through Barriers and Keep Leveling Up Your Success" (McGraw Hill, November 2022), which draws from her own personal story of rising from humble beginnings to achieve great success.
Jones is an active member of several boards of directors, including AMN Healthcare, Inc., Barnes Group Inc., and Masonite International Corp. She serves on the Audit and Nominating Governance committees. In addition, Jones is the Founder and CEO of The Board Curators, a company that curates senior executives on how to best prepare to serve on public and private boards.
Jones' expertise and insights have been widely featured in leading media outlets such as Fox Business, TD Ameritrade, CNBC Make It, Cheddar.com, Fast Company, Fortune, and Forbes. In February 2023, she was recognized by Fortune Magazine as one of the trailblazing black executives changing the future of business.
She is a member of WBL, The Executive Leadership Council (ELC), CHIEF, Digital Directors Network (DDN), and The Accenture Cyber Security Council. Daphne earned her MBA and BS from Illinois State University.
Key boards: AMN Healthcare (Nasdaq: AMN), Barnes Group (NYSE: B), Masonite International (NYSE: DOOR)
Founder & Concierge
The Board Curators
-
Daphne E. Jones is a highly accomplished Fortune 500 CIO, digital leader, and board member with over 30 years of experience in general management and executive-level roles at leading companies such as IBM, Johnson & Johnson, Hospira, and General Electric. With a reputation for innovation and driving business growth, Jones has held several leadership positions at GE, including SVP for Future of Work, SVP and CIO for Product Engineering, Imaging, and Ultrasound, and Senior Executive and CIO for Global Services, where she led a $13 billion segment of GE Healthcare.
Jones is also an acclaimed author, having recently published her first book, "WIN WHEN THEY SAY YOU WON’T: Break Through Barriers and Keep Leveling Up Your Success" (McGraw Hill, November 2022), which draws from her own personal story of rising from humble beginnings to achieve great success.
Jones is an active member of several boards of directors, including AMN Healthcare, Inc., Barnes Group Inc., and Masonite International Corp. She serves on the Audit and Nominating Governance committees. In addition, Jones is the Founder and CEO of The Board Curators, a company that curates senior executives on how to best prepare to serve on public and private boards.
Jones' expertise and insights have been widely featured in leading media outlets such as Fox Business, TD Ameritrade, CNBC Make It, Cheddar.com, Fast Company, Fortune, and Forbes. In February 2023, she was recognized by Fortune Magazine as one of the trailblazing black executives changing the future of business.
She is a member of WBL, The Executive Leadership Council (ELC), CHIEF, Digital Directors Network (DDN), and The Accenture Cyber Security Council. Daphne earned her MBA and BS from Illinois State University.
Key boards: AMN Healthcare (Nasdaq: AMN), Barnes Group (NYSE: B), Masonite International (NYSE: DOOR)
Mia Jung MBA
Talent Partner
WCAS
-
Mia Jung is a Talent Partner on the Healthcare team of WCAS, having joined in 2022. Ms. Jung focuses on executive talent strategy and management and is responsible for helping WCAS’s healthcare companies build best-in-class leadership teams. She brings nearly a decade of executive search experience, having placed hundreds of leaders in many of the healthcare industry’s top organizations.
Prior to joining WCAS, Ms. Jung served as a Partner at Oxeon Partners, a leading retained executive search and investments firm where she partnered with innovative healthcare organizations, boards, and investors to build high-performing, diverse leadership teams. Ms. Jung co-founded Break Into The Boardroom, an initiative that seeks to drive gender parity in privately held healthcare boards. She currently sits on the Board of Abzena, a WCAS portfolio company. Prior to her career in executive search, Ms. Jung held commercial leadership roles in the pharmaceutical and medical technology industries at companies such as Merck, Guidant, and Boston Scientific.
Key boards: Abzena
Talent Partner
WCAS
-
Mia Jung is a Talent Partner on the Healthcare team of WCAS, having joined in 2022. Ms. Jung focuses on executive talent strategy and management and is responsible for helping WCAS’s healthcare companies build best-in-class leadership teams. She brings nearly a decade of executive search experience, having placed hundreds of leaders in many of the healthcare industry’s top organizations.
Prior to joining WCAS, Ms. Jung served as a Partner at Oxeon Partners, a leading retained executive search and investments firm where she partnered with innovative healthcare organizations, boards, and investors to build high-performing, diverse leadership teams. Ms. Jung co-founded Break Into The Boardroom, an initiative that seeks to drive gender parity in privately held healthcare boards. She currently sits on the Board of Abzena, a WCAS portfolio company. Prior to her career in executive search, Ms. Jung held commercial leadership roles in the pharmaceutical and medical technology industries at companies such as Merck, Guidant, and Boston Scientific.
Key boards: Abzena
Nancy Lurker
Executive Vice Chair
EyePoint Pharmaceuticals
-
As Executive Vice Chair and formerly President and Chief Executive Officer, Nancy leads EyePoint Pharmaceuticals in its mission to improve the lives of people facing serious eye disorders. During her more than 30 years in the pharmaceutical industry, Ms. Lurker has driven scientific and commercial innovation working with both public and private companies from start-ups to the Fortune 500 to bring innovative therapies and diagnostic solutions to patients.
Prior to joining EyePoint in 2016, Ms. Lurker was President and CEO and Board Director of PDI, Inc., a NASDAQ-listed healthcare commercialization company which sold to Publicis Health. Before joining PDI, she was Senior Vice President and Chief Marketing Officer at Novartis Pharmaceuticals. She also served as President and CEO of ImpactRx, Inc., a privately held healthcare information company. Prior to ImpactRx, Ms. Lurker was Group VP, Global Primary Care Products for Pharmacia Corporation, and a member of Pharmacia’s US Executive Management Committee. She began her career as a Senior Medical Representative at Bristol Myers Squibb, where she quickly rose to Senior Director of Worldwide Cardiovascular Franchise Management, overseeing numerous successful drug launches.
Ms. Lurker currently serves on the Board of Directors of Eyepoint Pharmaceuticals, Altasciences, and Aquestive Therapeutics; as a member of the Novo Holdings Advisory Board; and on the Stanford School of Medicine Masters in Translational Medicine Advisory Board. She has previously held positions on the Boards of Cancer Treatment Centers of America, Mallinckrodt Pharmaceuticals, Auxilium Pharmaceuticals, PDI, Elan Pharmaceuticals, Conjuchem, and ImpactRx.
Ms. Lurker holds a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. Dedicating her career to maximizing the potential of science to improve the lives of patients, Ms. Lurker is passionate about supporting the future of STEM and engaging with the critical thinkers and innovators of tomorrow.
Key boards: Eyepoint Pharmaceuticals (NASDAQ: EYPT), Altasciences, Aquestive Therapeutics (NASDAQ: AQST)
Executive Vice Chair
EyePoint Pharmaceuticals
-
As Executive Vice Chair and formerly President and Chief Executive Officer, Nancy leads EyePoint Pharmaceuticals in its mission to improve the lives of people facing serious eye disorders. During her more than 30 years in the pharmaceutical industry, Ms. Lurker has driven scientific and commercial innovation working with both public and private companies from start-ups to the Fortune 500 to bring innovative therapies and diagnostic solutions to patients.
Prior to joining EyePoint in 2016, Ms. Lurker was President and CEO and Board Director of PDI, Inc., a NASDAQ-listed healthcare commercialization company which sold to Publicis Health. Before joining PDI, she was Senior Vice President and Chief Marketing Officer at Novartis Pharmaceuticals. She also served as President and CEO of ImpactRx, Inc., a privately held healthcare information company. Prior to ImpactRx, Ms. Lurker was Group VP, Global Primary Care Products for Pharmacia Corporation, and a member of Pharmacia’s US Executive Management Committee. She began her career as a Senior Medical Representative at Bristol Myers Squibb, where she quickly rose to Senior Director of Worldwide Cardiovascular Franchise Management, overseeing numerous successful drug launches.
Ms. Lurker currently serves on the Board of Directors of Eyepoint Pharmaceuticals, Altasciences, and Aquestive Therapeutics; as a member of the Novo Holdings Advisory Board; and on the Stanford School of Medicine Masters in Translational Medicine Advisory Board. She has previously held positions on the Boards of Cancer Treatment Centers of America, Mallinckrodt Pharmaceuticals, Auxilium Pharmaceuticals, PDI, Elan Pharmaceuticals, Conjuchem, and ImpactRx.
Ms. Lurker holds a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. Dedicating her career to maximizing the potential of science to improve the lives of patients, Ms. Lurker is passionate about supporting the future of STEM and engaging with the critical thinkers and innovators of tomorrow.
Key boards: Eyepoint Pharmaceuticals (NASDAQ: EYPT), Altasciences, Aquestive Therapeutics (NASDAQ: AQST)
Mary Anne Mason
CEO
Mason Strategic Advisors
Mary Anne Mason brings over three decades of experience helping healthcare companies grow, scale, and exit successfully. Her experience spans whiteboard startups to large publicly traded companies, including Caremark, Baxter International, and Axia Health Management, widely known for the SilverSneakers® Fitness Program.
Mary Anne works with private equity firms as a board member and advisor to their portfolio companies. She guides these companies to tackle strategic challenges, enhance go-to-market strategy, attract A-player talent, connect with opportunities in the market, and accelerate growth. She has served as an operating partner and independent director. As a “been-there-done-that” entrepreneur, Mary Anne deeply understands the DNA of these companies and what it takes to accelerate growth and value creation. Her unparalleled network and unique ability to identify and foster strong relationships make her an invaluable resource.
Mary Anne served as a founding partner of Axia Health Management, beginning at startup, scaling, and later participating in the successful sale to Healthways for $450 million. She led business development for Caremark, a company that grew from a startup physician practice management business to $1 billion in revenue in just four years. She was general manager with P&L responsibility for a $300 million division of Baxter International.
Mary Anne’s board service includes AccessOne, a portfolio company of Frontier Growth at the intersection of healthcare and fintech; Linkwell Health, a member engagement company backed by HLM Ventures and Spark Capital; and Tridiuum (exited to New Directions Behavioral Health), a digital behavioral health company, backed by Fresenius, Sopris Capital, and Martinson Ventures. She is an independent director on the board of The Vitality Group. She serves on the board of WBL and is a former Board Program faculty mentor. Mary Anne is a frequent speaker and advocate for women on their journey to board service.
CEO
Mason Strategic Advisors
Mary Anne Mason brings over three decades of experience helping healthcare companies grow, scale, and exit successfully. Her experience spans whiteboard startups to large publicly traded companies, including Caremark, Baxter International, and Axia Health Management, widely known for the SilverSneakers® Fitness Program.
Mary Anne works with private equity firms as a board member and advisor to their portfolio companies. She guides these companies to tackle strategic challenges, enhance go-to-market strategy, attract A-player talent, connect with opportunities in the market, and accelerate growth. She has served as an operating partner and independent director. As a “been-there-done-that” entrepreneur, Mary Anne deeply understands the DNA of these companies and what it takes to accelerate growth and value creation. Her unparalleled network and unique ability to identify and foster strong relationships make her an invaluable resource.
Mary Anne served as a founding partner of Axia Health Management, beginning at startup, scaling, and later participating in the successful sale to Healthways for $450 million. She led business development for Caremark, a company that grew from a startup physician practice management business to $1 billion in revenue in just four years. She was general manager with P&L responsibility for a $300 million division of Baxter International.
Mary Anne’s board service includes AccessOne, a portfolio company of Frontier Growth at the intersection of healthcare and fintech; Linkwell Health, a member engagement company backed by HLM Ventures and Spark Capital; and Tridiuum (exited to New Directions Behavioral Health), a digital behavioral health company, backed by Fresenius, Sopris Capital, and Martinson Ventures. She is an independent director on the board of The Vitality Group. She serves on the board of WBL and is a former Board Program faculty mentor. Mary Anne is a frequent speaker and advocate for women on their journey to board service.
Krista McKerracher
Managing Director
Fig Advisory LLC
Krista McKerracher is a retired biopharmaceutical leader with 35+ years of experience spanning Canadian, U.S. & global commercial and development roles. She is known for bringing a strong commercial orientation to the drug development process.
In her last corporate role, McKerracher was VP, Head of Hemoglobinopathy Programs at CRISPR Therapeutics (NASDAQ: CRSP) where she took the first CRISPR-edited autologous cellular program through IND and into the clinic. Previously, McKerracher was Vice President & Global Program Franchise Head at Novartis Oncology, where she directed a large cross-functional team of drug development professionals. Prior to Novartis, McKerracher held a series of roles over 14 years at the Johnson & Johnson family of companies in Canada and the US.
In 2017, McKerracher founded FIG Advisory LLC, a consultancy serving early-stage companies on development and fund-raising strategy. She serves on the Board of Nervgen Pharma (TSXV: NGEN, OTCQX: NGENF; Chair, Nomination & Governance Committee; member, Compensation and Science Committees). She serves on Advisory Boards to Hemex Health, Cureleads, and BioAxone Biosciences, and is a mentor at Springboard, an incubator for female-led healthcare and technology companies. She previously served on the Alumni Council and the Capital Campaign Committee at the University of Waterloo.
McKerracher holds a BSc (Hon) in Applied Health Studies from the University of Waterloo and an MBA from York University. She is an avid skier, golfer, and boater who loves to cook and learn all she can about wine.
Key boards: Nervgen Pharma (TSXV: NGEN, OTCQX: NGENF) (Nomination & Governance Committee Chair; Compensation and Science Committees), Hemex Health Advisory Board, Cureleads Advisory Board, BioAxone Biosciences Advisory Board
Managing Director
Fig Advisory LLC
Krista McKerracher is a retired biopharmaceutical leader with 35+ years of experience spanning Canadian, U.S. & global commercial and development roles. She is known for bringing a strong commercial orientation to the drug development process.
In her last corporate role, McKerracher was VP, Head of Hemoglobinopathy Programs at CRISPR Therapeutics (NASDAQ: CRSP) where she took the first CRISPR-edited autologous cellular program through IND and into the clinic. Previously, McKerracher was Vice President & Global Program Franchise Head at Novartis Oncology, where she directed a large cross-functional team of drug development professionals. Prior to Novartis, McKerracher held a series of roles over 14 years at the Johnson & Johnson family of companies in Canada and the US.
In 2017, McKerracher founded FIG Advisory LLC, a consultancy serving early-stage companies on development and fund-raising strategy. She serves on the Board of Nervgen Pharma (TSXV: NGEN, OTCQX: NGENF; Chair, Nomination & Governance Committee; member, Compensation and Science Committees). She serves on Advisory Boards to Hemex Health, Cureleads, and BioAxone Biosciences, and is a mentor at Springboard, an incubator for female-led healthcare and technology companies. She previously served on the Alumni Council and the Capital Campaign Committee at the University of Waterloo.
McKerracher holds a BSc (Hon) in Applied Health Studies from the University of Waterloo and an MBA from York University. She is an avid skier, golfer, and boater who loves to cook and learn all she can about wine.
Key boards: Nervgen Pharma (TSXV: NGEN, OTCQX: NGENF) (Nomination & Governance Committee Chair; Compensation and Science Committees), Hemex Health Advisory Board, Cureleads Advisory Board, BioAxone Biosciences Advisory Board
Sonia Millsom MPH
CEO
Oxeon
-
Sonia Millsom is the CEO of Oxeon, a trusted healthcare firm, powering change through talent, entrepreneurship, and investment. She is a veteran healthcare leader who has been at the forefront of value-based healthcare, with extensive experience growing mission-driven innovative companies, as well as serving as an adviser, board member, and investor.
Prior to joining Oxeon, Millsom served as the Chief Commercial Officer at Maven Clinic, a telemedicine-based virtual clinic for women and families, which achieved the first unicorn valuation in women and family health. Before joining Maven, she was Chief Growth Officer at Boston-based startup Iora Health, where she helped strengthen the organization’s revenue and oversaw an expansion that led to its $2.1 billion acquisition by One Medical.
Improving healthcare has been a personal mission for Sonia since her time as a Maternal and Child Health Peace Corps volunteer in Morocco — where, in the 1990s, she witnessed close-up how broken delivery systems lead to poor care. She is a professional mentor to budding healthcare leaders with Menttium, and a board member serving on the Audit and Compliance Committee for Clever Care Health Plan, which provides culturally sensitive health solutions for seniors. She also serves on the boards of Quilted Health and Suvida Health and holds advisory board member positions at Stellar Health, QHLTH, and Flourish Fund.
Sonia has a Master of Public Health degree from Columbia University and a Bachelor of Arts from Boston College. She resides in East Greenwich, Rhode Island, where she and her partner are raising the next generation of strong women as the parents of two daughters.
Key boards: Clever Care Health Plan (Audit and Compliance Committee), Quilted Health, Suvida Health
CEO
Oxeon
-
Sonia Millsom is the CEO of Oxeon, a trusted healthcare firm, powering change through talent, entrepreneurship, and investment. She is a veteran healthcare leader who has been at the forefront of value-based healthcare, with extensive experience growing mission-driven innovative companies, as well as serving as an adviser, board member, and investor.
Prior to joining Oxeon, Millsom served as the Chief Commercial Officer at Maven Clinic, a telemedicine-based virtual clinic for women and families, which achieved the first unicorn valuation in women and family health. Before joining Maven, she was Chief Growth Officer at Boston-based startup Iora Health, where she helped strengthen the organization’s revenue and oversaw an expansion that led to its $2.1 billion acquisition by One Medical.
Improving healthcare has been a personal mission for Sonia since her time as a Maternal and Child Health Peace Corps volunteer in Morocco — where, in the 1990s, she witnessed close-up how broken delivery systems lead to poor care. She is a professional mentor to budding healthcare leaders with Menttium, and a board member serving on the Audit and Compliance Committee for Clever Care Health Plan, which provides culturally sensitive health solutions for seniors. She also serves on the boards of Quilted Health and Suvida Health and holds advisory board member positions at Stellar Health, QHLTH, and Flourish Fund.
Sonia has a Master of Public Health degree from Columbia University and a Bachelor of Arts from Boston College. She resides in East Greenwich, Rhode Island, where she and her partner are raising the next generation of strong women as the parents of two daughters.
Key boards: Clever Care Health Plan (Audit and Compliance Committee), Quilted Health, Suvida Health
Melissa Mounce
Managing Director
GTCR
-
Melissa Mounce joined GTCR in 2019 as a Managing Director, Leadership Talent & Diversity. She advises GTCR portfolio companies on human resources initiatives and leads DEI initiatives across the portfolio companies, at the Board level, and within the firm. Melissa is a member of GTCR’s ESG-DEI Steering Committee and co-leads GTCR’s DEI Council and the newly established GTCR Women’s Leadership Group. She also leads the CHRO Roundtable for all portfolio company HR leaders.
Prior to joining GTCR, Melissa was the Principal of Human Capital at Baird Capital. She also has held business strategy and consulting roles at Motorola, E&Y, and strategic human capital and talent management roles at PNC Bank, Aon, and Abbott.
Melissa earned a BA in international business from Illinois State University and an MBA from Northern Illinois University. She is a member and serves on the board of The International Women’s Forum (Chicago Chapter). She was named a 2022 Crain’s Chicago Business Notable Executive in HR and DEI and recognized as a 2021 Mergers & Acquisitions Top 25 Most Influential Women in Mid-Market M&A and a PE Leader in DEI.
Key boards: The International Women's Forum (Chicago Chapter)
Managing Director
GTCR
-
Melissa Mounce joined GTCR in 2019 as a Managing Director, Leadership Talent & Diversity. She advises GTCR portfolio companies on human resources initiatives and leads DEI initiatives across the portfolio companies, at the Board level, and within the firm. Melissa is a member of GTCR’s ESG-DEI Steering Committee and co-leads GTCR’s DEI Council and the newly established GTCR Women’s Leadership Group. She also leads the CHRO Roundtable for all portfolio company HR leaders.
Prior to joining GTCR, Melissa was the Principal of Human Capital at Baird Capital. She also has held business strategy and consulting roles at Motorola, E&Y, and strategic human capital and talent management roles at PNC Bank, Aon, and Abbott.
Melissa earned a BA in international business from Illinois State University and an MBA from Northern Illinois University. She is a member and serves on the board of The International Women’s Forum (Chicago Chapter). She was named a 2022 Crain’s Chicago Business Notable Executive in HR and DEI and recognized as a 2021 Mergers & Acquisitions Top 25 Most Influential Women in Mid-Market M&A and a PE Leader in DEI.
Key boards: The International Women's Forum (Chicago Chapter)
Leif Murphy
CEO
TeamHealth
-
Leif M. Murphy joined TeamHealth as President and Chief Executive Officer in September 2016. He is also a member of the TeamHealth Board of Directors.
Throughout his career, Mr. Murphy has held numerous executive-level positions in healthcare operations, business development, and finance, including Executive Vice President and Chief Financial Officer of LifePoint Health, Inc. since September 2013 and as their Chief Development Officer starting in 2011, President and Chief Executive Officer of DSI Renal, Inc. from 2008 until 2011, and Senior Vice President and Treasurer of CVS/Caremark, Inc. from 2006 to 2008. Mr. Murphy also previously held leadership positions at Renal Care Group, Inc., National Nephrology Associates, Inc., and HealthSouth Corporation.
Mr. Murphy is a member of the board of directors of the Nashville Branch of the Federal Reserve Bank of Atlanta and the Nashville Healthcare Council. He earned his bachelor’s degree from Furman University and a master’s degree in business administration from The College of William and Mary.
Key boards: TeamHealth, Federal Reserve Bank of Atlanta (Nashville Branch), Nashville Healthcare Council
CEO
TeamHealth
-
Leif M. Murphy joined TeamHealth as President and Chief Executive Officer in September 2016. He is also a member of the TeamHealth Board of Directors.
Throughout his career, Mr. Murphy has held numerous executive-level positions in healthcare operations, business development, and finance, including Executive Vice President and Chief Financial Officer of LifePoint Health, Inc. since September 2013 and as their Chief Development Officer starting in 2011, President and Chief Executive Officer of DSI Renal, Inc. from 2008 until 2011, and Senior Vice President and Treasurer of CVS/Caremark, Inc. from 2006 to 2008. Mr. Murphy also previously held leadership positions at Renal Care Group, Inc., National Nephrology Associates, Inc., and HealthSouth Corporation.
Mr. Murphy is a member of the board of directors of the Nashville Branch of the Federal Reserve Bank of Atlanta and the Nashville Healthcare Council. He earned his bachelor’s degree from Furman University and a master’s degree in business administration from The College of William and Mary.
Key boards: TeamHealth, Federal Reserve Bank of Atlanta (Nashville Branch), Nashville Healthcare Council
Miriam Paramore
Founder & CEO
RxUtility
-
Miriam Paramore has been influencing the direction of the healthcare technology industry for more than 30 years. Her contributions have had a significant impact on the major healthcare business sectors – providers, payers, pharma, and, most importantly, patients. It has been Miriam’s life's work to improve the U.S. healthcare system through the power of information. She is an expert in healthcare IT as well as healthcare data and the rules that govern it.
Miriam is an operating advisor at Goldman Sachs and a senior advisor at Sixth Street growth equity. She is a member of the Board of Directors of Medsphere, a private health IT company that provides EHR, RCM, and other IT solutions for providers.
Miriam is the immediate past President and Chief Strategy Officer of OptimizeRx (NASDAQ: OPRX), a digital health company that connects life sciences, physicians, and patients in order to improve access, affordability, and adherence. She oversaw all initiatives to diversify the organization’s workforce by founding its first DEI program. She led the company’s corporate development function working with the investment community on, buy, and partner opportunities.
Previously, Miriam held C-suite roles in several health tech companies. Notably, she ran enterprise-wide strategy and product development as executive vice president for Emdeon, now known as Change Healthcare. Her previous board of director and advisory board roles include RxRevu, a prescription decision support technology company; CareSource, a Medicaid managed care plan; HIMSS; the Louisville Health Information Exchange; and the eHealth Committee for the Commonwealth of Kentucky.
As an investor, Miriam connects health tech entrepreneurs with capital partners and puts her money to work with great people to drive ideas she believes in. She is currently invested in several early-stage health tech companies. Miriam was a founding investor at NueCura, a Nashville-based healthcare angel investment group, where she sourced deals and advised several portfolio companies.
Key boards: Medsphere, Human-Centered Health
Founder & CEO
RxUtility
-
Miriam Paramore has been influencing the direction of the healthcare technology industry for more than 30 years. Her contributions have had a significant impact on the major healthcare business sectors – providers, payers, pharma, and, most importantly, patients. It has been Miriam’s life's work to improve the U.S. healthcare system through the power of information. She is an expert in healthcare IT as well as healthcare data and the rules that govern it.
Miriam is an operating advisor at Goldman Sachs and a senior advisor at Sixth Street growth equity. She is a member of the Board of Directors of Medsphere, a private health IT company that provides EHR, RCM, and other IT solutions for providers.
Miriam is the immediate past President and Chief Strategy Officer of OptimizeRx (NASDAQ: OPRX), a digital health company that connects life sciences, physicians, and patients in order to improve access, affordability, and adherence. She oversaw all initiatives to diversify the organization’s workforce by founding its first DEI program. She led the company’s corporate development function working with the investment community on, buy, and partner opportunities.
Previously, Miriam held C-suite roles in several health tech companies. Notably, she ran enterprise-wide strategy and product development as executive vice president for Emdeon, now known as Change Healthcare. Her previous board of director and advisory board roles include RxRevu, a prescription decision support technology company; CareSource, a Medicaid managed care plan; HIMSS; the Louisville Health Information Exchange; and the eHealth Committee for the Commonwealth of Kentucky.
As an investor, Miriam connects health tech entrepreneurs with capital partners and puts her money to work with great people to drive ideas she believes in. She is currently invested in several early-stage health tech companies. Miriam was a founding investor at NueCura, a Nashville-based healthcare angel investment group, where she sourced deals and advised several portfolio companies.
Key boards: Medsphere, Human-Centered Health
Irem Rami
Principal
Norwest Venture Partners
Irem Rami brings over a decade of investing and operating experience across various stages of healthcare services and healthcare technology companies. At Norwest Venture Partners, she focuses on venture and growth equity opportunities across healthcare services, healthcare IT, pharma services, and digital health.
Previously, Irem worked at Summit Partners where she focused on healthcare growth stage businesses and was a board member or observer for four companies across risk-based providers and healthcare tech-enabled services. She was also a Principal at McKesson Ventures where she led investments, helped source or served as a board observer for Landmark Health (acquired by Optum), Aledade, IVX Health (recapped by Great Hill Partners), OncoHealth (formerly Oncology Analytics), SHYFT Analytics (acquired by Medidata), Aetion, Curana Health (formerly AllyAlign), Komodo Health, Kyruus and Evariant (acquired by Healthgrades).
Before McKesson, Irem was part of the founding team at Burd Health where she led the development and implementation of value-based initiatives for self-insured organizations across network management, pharmacy benefit management, and wellness products. She also held product and business development roles with healthcare startups Omada Health and Caremerge and was an intern at Andreessen Horowitz where she focused on digital health. Irem started her career as an investment associate at Madison Dearborn Partners and an investment banking analyst at Bank of America Merrill Lynch.
Irem holds a BS in biomedical engineering and economics, magna cum laude, from Duke University and an MBA from the Stanford Graduate School of Business, where she was an Arbuckle Leadership Fellow and Co-President of the Healthcare Club.
Key boards: Clever Care (Board observer), Monogram Health (Board observer)
Principal
Norwest Venture Partners
Irem Rami brings over a decade of investing and operating experience across various stages of healthcare services and healthcare technology companies. At Norwest Venture Partners, she focuses on venture and growth equity opportunities across healthcare services, healthcare IT, pharma services, and digital health.
Previously, Irem worked at Summit Partners where she focused on healthcare growth stage businesses and was a board member or observer for four companies across risk-based providers and healthcare tech-enabled services. She was also a Principal at McKesson Ventures where she led investments, helped source or served as a board observer for Landmark Health (acquired by Optum), Aledade, IVX Health (recapped by Great Hill Partners), OncoHealth (formerly Oncology Analytics), SHYFT Analytics (acquired by Medidata), Aetion, Curana Health (formerly AllyAlign), Komodo Health, Kyruus and Evariant (acquired by Healthgrades).
Before McKesson, Irem was part of the founding team at Burd Health where she led the development and implementation of value-based initiatives for self-insured organizations across network management, pharmacy benefit management, and wellness products. She also held product and business development roles with healthcare startups Omada Health and Caremerge and was an intern at Andreessen Horowitz where she focused on digital health. Irem started her career as an investment associate at Madison Dearborn Partners and an investment banking analyst at Bank of America Merrill Lynch.
Irem holds a BS in biomedical engineering and economics, magna cum laude, from Duke University and an MBA from the Stanford Graduate School of Business, where she was an Arbuckle Leadership Fellow and Co-President of the Healthcare Club.
Key boards: Clever Care (Board observer), Monogram Health (Board observer)
Linda Rebrovick
Board Director
HealthStream
-
Linda Rebrovick, CEO of Impact Corporate Consulting, has served on the boards of seven global and national public and private companies. Linda is currently serving as an independent corporate board director of Guidehouse, Inc., HealthStream, Inc. (Nasdaq: HSTM), CivicEye, and Consensus Point. Linda brings executive experience with some of the world’s largest technology and services companies, including IBM, KPMG, and Dell. She is leveraging her twenty-five years of board experience and over thirty years of management expertise to guide companies in the creation of shareholder value through inorganic and organic growth.
Linda excels in strategy, consulting, sales, marketing, and operations and has assisted her boards with the applications of innovative business and technology solutions. Through her forty-year career in the commercial and federal healthcare, government, consumer products, consulting, and financial services industries, Linda has built an extensive network of colleagues and customers.
Linda served on the board of Reliant Bancorp, Inc. (Nasdaq: RBNC), from May 2019 to January 2022, when the board guided management through a merger with United Community Bank, Inc. (Nasdaq: UCBI). She also served on the boards of KPMG, LLP; Tribridge Enterprise; and Pinnacle Financial Partners, Inc.
Linda is a 2021 Senior Fellow at Harvard University's Advanced Leadership Initiative. She received her BS, Marketing from Auburn University, Harbert College of Business. She has been recognized as a member of ODK and one of the Top 400 Women Graduates of the past 100 years at Auburn University. She currently serves on the Advisory Board, Harvard University, Edmond & Lily Safra Center for Ethics.
Key boards: Guidehouse, Inc.; HealthStream, Inc. (Nasdaq: HSTM) (Audit and Compensation Committees); CivicEye; Consensus Point
Board Director
HealthStream
-
Linda Rebrovick, CEO of Impact Corporate Consulting, has served on the boards of seven global and national public and private companies. Linda is currently serving as an independent corporate board director of Guidehouse, Inc., HealthStream, Inc. (Nasdaq: HSTM), CivicEye, and Consensus Point. Linda brings executive experience with some of the world’s largest technology and services companies, including IBM, KPMG, and Dell. She is leveraging her twenty-five years of board experience and over thirty years of management expertise to guide companies in the creation of shareholder value through inorganic and organic growth.
Linda excels in strategy, consulting, sales, marketing, and operations and has assisted her boards with the applications of innovative business and technology solutions. Through her forty-year career in the commercial and federal healthcare, government, consumer products, consulting, and financial services industries, Linda has built an extensive network of colleagues and customers.
Linda served on the board of Reliant Bancorp, Inc. (Nasdaq: RBNC), from May 2019 to January 2022, when the board guided management through a merger with United Community Bank, Inc. (Nasdaq: UCBI). She also served on the boards of KPMG, LLP; Tribridge Enterprise; and Pinnacle Financial Partners, Inc.
Linda is a 2021 Senior Fellow at Harvard University's Advanced Leadership Initiative. She received her BS, Marketing from Auburn University, Harbert College of Business. She has been recognized as a member of ODK and one of the Top 400 Women Graduates of the past 100 years at Auburn University. She currently serves on the Advisory Board, Harvard University, Edmond & Lily Safra Center for Ethics.
Key boards: Guidehouse, Inc.; HealthStream, Inc. (Nasdaq: HSTM) (Audit and Compensation Committees); CivicEye; Consensus Point
Patty Riskind MBA
CEO
Orbita; Boards: Orbita; Academy of Nutrition and Dietetics; Northwestern University Kellogg; Intus Care
Patty Riskind is CEO of Orbita, a conversational AI company, focused on automating workflows in healthcare and life sciences. Patty was previously Head of Global Healthcare for Qualtrics, an experience management technology company. She has served on several venture-backed private boards as well as a public (non-physician) board member of the Accreditation Council for Graduate Medical Education (ACGME) on its compensation, audit, and finance committees.
Previously, Patty was Chief Client Experience Officer at Press Ganey Associates. Prior to Press Ganey, Patty was the Founder and CEO of PatientImpact LLC, the first e-survey SaaS company in the healthcare industry. Press Ganey acquired PatientImpact in 2009.
Before starting PatientImpact, Patty co-founded and was CEO of 3d Health, Inc., an ambulatory strategy consulting firm; was COO of Tiber Group, now part of Guidehouse Consulting; served as Executive Director of Business Development for Health Forum, a subsidiary of the American Hospital Association; was VP Operations for Dorenfest & Associates, a healthcare IT market research firm acquired by HIMSS Analytics; and VP Product Development for Sachs Group, a health care predictive modeling software firm.
Patty has a Bachelor of Arts degree with honors from Brown University and an MBA from the Kellogg School of Management at Northwestern University.
CEO
Orbita; Boards: Orbita; Academy of Nutrition and Dietetics; Northwestern University Kellogg; Intus Care
Patty Riskind is CEO of Orbita, a conversational AI company, focused on automating workflows in healthcare and life sciences. Patty was previously Head of Global Healthcare for Qualtrics, an experience management technology company. She has served on several venture-backed private boards as well as a public (non-physician) board member of the Accreditation Council for Graduate Medical Education (ACGME) on its compensation, audit, and finance committees.
Previously, Patty was Chief Client Experience Officer at Press Ganey Associates. Prior to Press Ganey, Patty was the Founder and CEO of PatientImpact LLC, the first e-survey SaaS company in the healthcare industry. Press Ganey acquired PatientImpact in 2009.
Before starting PatientImpact, Patty co-founded and was CEO of 3d Health, Inc., an ambulatory strategy consulting firm; was COO of Tiber Group, now part of Guidehouse Consulting; served as Executive Director of Business Development for Health Forum, a subsidiary of the American Hospital Association; was VP Operations for Dorenfest & Associates, a healthcare IT market research firm acquired by HIMSS Analytics; and VP Product Development for Sachs Group, a health care predictive modeling software firm.
Patty has a Bachelor of Arts degree with honors from Brown University and an MBA from the Kellogg School of Management at Northwestern University.
Eleanor Rosiak
CEO
WBL
Eleanor Rosiak is the CEO of the Women Business Leaders of the U.S. Health Care Industry Foundation based in Washington, D.C. She is responsible for the day-to-day operations of the organization and the organization’s governance activities. Additionally, she focuses on WBL’s corporate governance-related initiatives, such as working with board search firms and other individuals to seek out corporate board opportunities for WBL’s members.
She authored a chapter of Answering the Call, WBL’s publication about the duties, risks, and rewards of corporate governance. Eleanor joined WBL’s staff in 2004 as a Research Assistant. She holds a B.A. in Economics from the University of Virginia where she graduated with Honors with a minor in Politics. She enjoys Mexican food, riding bikes that go nowhere, and spending time with her husband and two young daughters.
CEO
WBL
Eleanor Rosiak is the CEO of the Women Business Leaders of the U.S. Health Care Industry Foundation based in Washington, D.C. She is responsible for the day-to-day operations of the organization and the organization’s governance activities. Additionally, she focuses on WBL’s corporate governance-related initiatives, such as working with board search firms and other individuals to seek out corporate board opportunities for WBL’s members.
She authored a chapter of Answering the Call, WBL’s publication about the duties, risks, and rewards of corporate governance. Eleanor joined WBL’s staff in 2004 as a Research Assistant. She holds a B.A. in Economics from the University of Virginia where she graduated with Honors with a minor in Politics. She enjoys Mexican food, riding bikes that go nowhere, and spending time with her husband and two young daughters.
Mary Rotunno
Board Member
Vistagen
-
Mary Rotunno is a mission-driven health care C-suite executive, public corporate board director, and committee member with the strategic vision to critically think through complex challenges, see around corners, and mitigate risk. As a clinician and leader, she brings insight, gained through empathy and listening, and industry expertise from patient and health system perspectives to public/private company boards in pharma, health IT, biotech, population health management and value-based care, fitness/wellness models, and products.
Mary sits on a number of boards, including VistaGen Therapeutics Inc. (NASDAQ: VTGN), where she serves on the Audit Committee and chairs the Nom/Gov Committee; SaNOtize Research and Development, where she chairs the Compensation Committee; and Momentum for Health, where she served as board chair for two and a half years. She is also an advisory board member for the Business/Leadership Ethics Advisory Council at Markkula Center at Santa Clara University.
Mary’s 30+ year commitment to servant leadership began as a registered nurse and transitioned to health care law. She currently serves on the Executive Leadership Team and as General Counsel for El Camino Health, a $1.2B revenue health care system, named one of the World’s Best Hospitals in 2022 by Newsweek. Providing strategic governance, she advises on enterprise risk, health system strategy, restructuring, and strategic partnerships, while diplomatically challenging thinking, building consensus, and anticipating risk to advance corporate strategy.
Mary’s deep commitment to the underserved led her to establish the Medical Legal Clinic, forging partnerships for funding legal/social services to low-income patients. She promotes education and philanthropic support for women’s programs, services, and grants at St. Mary's Medical Center.
Key boards: VistaGen Therapeutics Inc. (NASDAQ: VTGN) (Audit and Nom/Gov Committees), SaNOtize Research and Development (Compensation Committee), Momentum for Health
Board Member
Vistagen
-
Mary Rotunno is a mission-driven health care C-suite executive, public corporate board director, and committee member with the strategic vision to critically think through complex challenges, see around corners, and mitigate risk. As a clinician and leader, she brings insight, gained through empathy and listening, and industry expertise from patient and health system perspectives to public/private company boards in pharma, health IT, biotech, population health management and value-based care, fitness/wellness models, and products.
Mary sits on a number of boards, including VistaGen Therapeutics Inc. (NASDAQ: VTGN), where she serves on the Audit Committee and chairs the Nom/Gov Committee; SaNOtize Research and Development, where she chairs the Compensation Committee; and Momentum for Health, where she served as board chair for two and a half years. She is also an advisory board member for the Business/Leadership Ethics Advisory Council at Markkula Center at Santa Clara University.
Mary’s 30+ year commitment to servant leadership began as a registered nurse and transitioned to health care law. She currently serves on the Executive Leadership Team and as General Counsel for El Camino Health, a $1.2B revenue health care system, named one of the World’s Best Hospitals in 2022 by Newsweek. Providing strategic governance, she advises on enterprise risk, health system strategy, restructuring, and strategic partnerships, while diplomatically challenging thinking, building consensus, and anticipating risk to advance corporate strategy.
Mary’s deep commitment to the underserved led her to establish the Medical Legal Clinic, forging partnerships for funding legal/social services to low-income patients. She promotes education and philanthropic support for women’s programs, services, and grants at St. Mary's Medical Center.
Key boards: VistaGen Therapeutics Inc. (NASDAQ: VTGN) (Audit and Nom/Gov Committees), SaNOtize Research and Development (Compensation Committee), Momentum for Health
Jean Rush MBA
Board Director
Addus Homecare
Jean Rush is an experienced CEO and Director with extensive experience in dramatically increasing business, profit, and market share growth for several companies within multi-billion dollar corporations. Her expertise encompasses government, commercial, and international healthcare. She was most recently the Executive Vice President of Government Markets at Highmark where she had P&L responsibility for Highmark’s $7B highly regulated government businesses, including Medicare, Medicaid, Individual and Small Group markets. In this role, Ms. Rush was responsible for the $1B financial turnaround of Highmark’s government businesses within a two-year period.
Prior to joining Highmark, Ms. Rush was Senior Vice President of Complex Care for Centene Corporation, with P&L responsibility for the Long Term Care and Medicare/Duals business across all Centene markets. In this role, she completed an operational turnaround of Centene’s Medicare business, positioning it for future growth including the successful launch of five Dual Demonstration projects. Prior to this position, Ms. Rush served as Senior Vice President of Health Plan Operations for Centene where she had P&L responsibility for six Medicaid and Medicare health plans across the country. Ms. Rush has served as the CEO and Plan President of Kentucky Spirit (a start-up health plan), and as the President of CIGNA Government Services, a wholly owned subsidiary of CIGNA, where her company won several large government procurements, launched a joint venture with BCBS of Tennessee, and was awarded the prestigious Excellence (Baldrige) Award for the state of Tennessee.
Ms. Rush earned her BA from Boston College and her MBA from the University of Connecticut. She recently earned the CERT Certificate in Cyber-Security Oversight from Carnegie Mellon University. Ms. Rush currently serves on the Board of Directors for Addus HomeCare (Nasdaq: ADUS) and is on the Audit and Compensation Committees of the Board. She is also on the Board for Eventus WholeHealth (where she serves on the Audit Committee and Chairs the Compliance Committee), Women Business Leaders in the US Healthcare Industry (where she serves on the Compensation Committee), Little Spurs Pediatric Urgent Care (where she serves on the Audit Committee and Chairs the Compliance Committee) and HomeFree Pharmacy Services. In addition, Ms. Rush is on the Advisory Boards for Aarete and The Hangout Spot, two privately owned companies in the healthcare space.
Key boards: Addus HomeCare (Nasdaq: ADUS) (Audit and Compensation Committees), Eventus WholeHealth (Audit and Compliance Committees), Little Spurs Pediatric Urgent Care (Audit and Compliance Committees)
Board Director
Addus Homecare
Jean Rush is an experienced CEO and Director with extensive experience in dramatically increasing business, profit, and market share growth for several companies within multi-billion dollar corporations. Her expertise encompasses government, commercial, and international healthcare. She was most recently the Executive Vice President of Government Markets at Highmark where she had P&L responsibility for Highmark’s $7B highly regulated government businesses, including Medicare, Medicaid, Individual and Small Group markets. In this role, Ms. Rush was responsible for the $1B financial turnaround of Highmark’s government businesses within a two-year period.
Prior to joining Highmark, Ms. Rush was Senior Vice President of Complex Care for Centene Corporation, with P&L responsibility for the Long Term Care and Medicare/Duals business across all Centene markets. In this role, she completed an operational turnaround of Centene’s Medicare business, positioning it for future growth including the successful launch of five Dual Demonstration projects. Prior to this position, Ms. Rush served as Senior Vice President of Health Plan Operations for Centene where she had P&L responsibility for six Medicaid and Medicare health plans across the country. Ms. Rush has served as the CEO and Plan President of Kentucky Spirit (a start-up health plan), and as the President of CIGNA Government Services, a wholly owned subsidiary of CIGNA, where her company won several large government procurements, launched a joint venture with BCBS of Tennessee, and was awarded the prestigious Excellence (Baldrige) Award for the state of Tennessee.
Ms. Rush earned her BA from Boston College and her MBA from the University of Connecticut. She recently earned the CERT Certificate in Cyber-Security Oversight from Carnegie Mellon University. Ms. Rush currently serves on the Board of Directors for Addus HomeCare (Nasdaq: ADUS) and is on the Audit and Compensation Committees of the Board. She is also on the Board for Eventus WholeHealth (where she serves on the Audit Committee and Chairs the Compliance Committee), Women Business Leaders in the US Healthcare Industry (where she serves on the Compensation Committee), Little Spurs Pediatric Urgent Care (where she serves on the Audit Committee and Chairs the Compliance Committee) and HomeFree Pharmacy Services. In addition, Ms. Rush is on the Advisory Boards for Aarete and The Hangout Spot, two privately owned companies in the healthcare space.
Key boards: Addus HomeCare (Nasdaq: ADUS) (Audit and Compensation Committees), Eventus WholeHealth (Audit and Compliance Committees), Little Spurs Pediatric Urgent Care (Audit and Compliance Committees)
Lynn Shapiro Snyder JD
Senior Member
Epstein Becker & Green, P.C.
Lynn Shapiro Snyder is a Board Member and Senior Member of Epstein Becker Green in Washington, D.C., a law firm with one of the largest health care and life sciences practices in the country. There, she advises clients about federal, state, and international health law issues, including Medicare, Medicaid, TRICARE, compliance, and managed care issues. Her clients include health care providers, payors, pharmaceutical/device manufacturers, and those companies and financial services firms that support the health care industry, including management and separate board representations. She publishes extensively and is a frequent speaker, particularly on topics related to health reform, enterprise risk, and compliance. She has been at Epstein Becker Green for over 40 years.
Additionally, Lynn is the Founder, Chairperson, and President of the Women Business Leaders of the U.S. Health Care Industry Foundation (WBL), a non-profit that connects and convenes senior executive women from all across the health care industry. WBL’s focus is on helping these women expand their leadership, such as by serving on a board of directors. The organization has helped to propel hundreds of women to board directorships and C-suite positions.
Named a “Director to Watch,” Lynn is a leader in the governance arena, currently serving on the boards of EBG, Trustmark Companies, PT Solutions (a General Atlantic Company) and WBL. She also is on the advisory board of the Nashville Health Care Council and was most recently on the board of Apria (a Blackstone Company) before its sale. She authored Advancing Women in Business: 10 Best Practices and co-authored Answering the Call: Understanding the Duties, Risks and Rewards of Corporate Governance.
Senior Member
Epstein Becker & Green, P.C.
Lynn Shapiro Snyder is a Board Member and Senior Member of Epstein Becker Green in Washington, D.C., a law firm with one of the largest health care and life sciences practices in the country. There, she advises clients about federal, state, and international health law issues, including Medicare, Medicaid, TRICARE, compliance, and managed care issues. Her clients include health care providers, payors, pharmaceutical/device manufacturers, and those companies and financial services firms that support the health care industry, including management and separate board representations. She publishes extensively and is a frequent speaker, particularly on topics related to health reform, enterprise risk, and compliance. She has been at Epstein Becker Green for over 40 years.
Additionally, Lynn is the Founder, Chairperson, and President of the Women Business Leaders of the U.S. Health Care Industry Foundation (WBL), a non-profit that connects and convenes senior executive women from all across the health care industry. WBL’s focus is on helping these women expand their leadership, such as by serving on a board of directors. The organization has helped to propel hundreds of women to board directorships and C-suite positions.
Named a “Director to Watch,” Lynn is a leader in the governance arena, currently serving on the boards of EBG, Trustmark Companies, PT Solutions (a General Atlantic Company) and WBL. She also is on the advisory board of the Nashville Health Care Council and was most recently on the board of Apria (a Blackstone Company) before its sale. She authored Advancing Women in Business: 10 Best Practices and co-authored Answering the Call: Understanding the Duties, Risks and Rewards of Corporate Governance.
Teresa Sparks
Independent Director
Valtruis, Harrow, ATI Physical Therapy and InnovAge
-
Teresa Sparks recently joined the board of InnovAge (Nasdaq: INNV), a market leader in managing the care of high-cost, dual-eligible seniors, enabling seniors to age independently in their own homes for as long as possible. In addition, she serves on the board of ATI Physical Therapy (NYSE: ATIP), providing research-based rehabilitation services, and Harrow Health (Nasdaq: HROW), engaged in the development of ophthalmic pharmaceutical products. She also serves as a board member and advisor to privately held, innovative healthcare companies, including Valtruis, which focuses on advancing value-based care.
Teresa previously served as the Executive Vice President and Chief Financial Officer for Envision, a leading provider of physician-led and post-acute care services, where she helped transform and modernize the company’s infrastructure. Prior to Envision, she was the interim Chief Financial Officer at Brookdale Senior Living. Before Brookdale Senior Living, Teresa served as Executive Vice President and Chief Financial Officer of Surgery Partners, which acquired Symbion, where she served in various positions, including Senior Vice President and Chief Financial Officer. Teresa began her career as an auditor at Deloitte.
Key boards: InnovAge (Nasdaq: INNV), ATI Physical Therapy (NYSE: ATIP), Harrow Health (Nasdaq: HROW)
Independent Director
Valtruis, Harrow, ATI Physical Therapy and InnovAge
-
Teresa Sparks recently joined the board of InnovAge (Nasdaq: INNV), a market leader in managing the care of high-cost, dual-eligible seniors, enabling seniors to age independently in their own homes for as long as possible. In addition, she serves on the board of ATI Physical Therapy (NYSE: ATIP), providing research-based rehabilitation services, and Harrow Health (Nasdaq: HROW), engaged in the development of ophthalmic pharmaceutical products. She also serves as a board member and advisor to privately held, innovative healthcare companies, including Valtruis, which focuses on advancing value-based care.
Teresa previously served as the Executive Vice President and Chief Financial Officer for Envision, a leading provider of physician-led and post-acute care services, where she helped transform and modernize the company’s infrastructure. Prior to Envision, she was the interim Chief Financial Officer at Brookdale Senior Living. Before Brookdale Senior Living, Teresa served as Executive Vice President and Chief Financial Officer of Surgery Partners, which acquired Symbion, where she served in various positions, including Senior Vice President and Chief Financial Officer. Teresa began her career as an auditor at Deloitte.
Key boards: InnovAge (Nasdaq: INNV), ATI Physical Therapy (NYSE: ATIP), Harrow Health (Nasdaq: HROW)
Karen Walker Johnson
Independent Director
The Oncology Institute (TOI); Clever Care Health Plan, a Norwest Ventures company; Adeii Health; March of Dimes
Karen Johnson served at March of Dimes as Interim President and CEO until August 2023 and currently serves as an advisor for the organization. As Interim CEO, she led the organization in the fight for the health of all moms and babies, and was responsible for all aspects of March of Dimes’ strategy, vision, and operations.
With more than 35 years of experience in the healthcare industry, Karen is a change catalyst and innovative problem solver with a proven track record of driving organizational transformation. Recognized for her strategic and business acumen, her passion is leadership development and positively impacting and improving the health status of vulnerable populations.
Prior to retirement in 2022, Karen was previously the Medicare Officer for Health Net, a Centene Corporation (CNC) company and Fortune 20 enterprise, where she managed a $3.5B+ revenue-generating multiproduct business. She also served on the Enterprise Diversity and Inclusion Council and Corporate Health Equity Task Force.
Karen has held executive leadership roles for UnitedHealthcare, Cigna, WellCare, Health Essentials, Cleveland Clinic, and Lake Health. She earned a Bachelor of Science degree in nursing from the University of Michigan in 1982 and a Juris Doctorate from Michigan State College of Law in 1986. She also holds an Executive Certificate from the Wharton School of Business.
Karen currently serves as a corporate director, Nominating/Governance Chair, and Compliance Committee member on the board of The Oncology Institute of Hope and Innovation (TOI). She also serves on the boards of Clever Care Health Plan and Bon Secours Mercy Health Foundation, and is a National Trustee of the Boys & Girls Clubs of America. Karen works with private equity firms and is currently an adviser to several early and mid-stage startup healthcare tech companies.
Independent Director
The Oncology Institute (TOI); Clever Care Health Plan, a Norwest Ventures company; Adeii Health; March of Dimes
Karen Johnson served at March of Dimes as Interim President and CEO until August 2023 and currently serves as an advisor for the organization. As Interim CEO, she led the organization in the fight for the health of all moms and babies, and was responsible for all aspects of March of Dimes’ strategy, vision, and operations.
With more than 35 years of experience in the healthcare industry, Karen is a change catalyst and innovative problem solver with a proven track record of driving organizational transformation. Recognized for her strategic and business acumen, her passion is leadership development and positively impacting and improving the health status of vulnerable populations.
Prior to retirement in 2022, Karen was previously the Medicare Officer for Health Net, a Centene Corporation (CNC) company and Fortune 20 enterprise, where she managed a $3.5B+ revenue-generating multiproduct business. She also served on the Enterprise Diversity and Inclusion Council and Corporate Health Equity Task Force.
Karen has held executive leadership roles for UnitedHealthcare, Cigna, WellCare, Health Essentials, Cleveland Clinic, and Lake Health. She earned a Bachelor of Science degree in nursing from the University of Michigan in 1982 and a Juris Doctorate from Michigan State College of Law in 1986. She also holds an Executive Certificate from the Wharton School of Business.
Karen currently serves as a corporate director, Nominating/Governance Chair, and Compliance Committee member on the board of The Oncology Institute of Hope and Innovation (TOI). She also serves on the boards of Clever Care Health Plan and Bon Secours Mercy Health Foundation, and is a National Trustee of the Boys & Girls Clubs of America. Karen works with private equity firms and is currently an adviser to several early and mid-stage startup healthcare tech companies.